Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

TXG Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 18, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for 10X Genomics Inc (TXG)

Based on 22 analysts giving stock ratings to 10X Genomics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
18
Buy
18
Hold
64
Sell
0
Strong Sell
0
10X Genomics Inc

10X Genomics Inc. Stock Analysis TXG

United States Health Care Mid Cap Report:
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. The company is headquartered in Pleasanton, California and currently employs 1,178 full-time employees. The company went IPO on 2019-09-12. The firm's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Read More

10X Genomics Inc (TXG) Chart

Key Statistics of 10X Genomics Inc (TXG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$31.30$33.36

Today's Open

$31.92

Volume

3.29M

P/E Ratio (TTM)

-

52 Week Range

$10.48$36.59

Market Cap

3.13B

Avg. Volume

3.27M

Dividend Yield

-

Financial Metrics & Statements of 10X Genomics Inc (TXG)

FAQ's for 10X Genomics Inc (TXG)

  • According to Musaffa’s Shariah screening methodology, 10X Genomics Inc (TXG) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes 10X Genomics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in 10X Genomics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of 10X Genomics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of 10X Genomics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of 10X Genomics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.